Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure

Liver International

Volumn 35, Issue 3, 2015, Pages 724-734

  Mehta, Gautam ^a   Mookerjee, Rajeshwar P ^a   Sharma, Vikram ^a   Jalan, Rajiv ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Hepatic circulation; Hepatic haemodynamics; Inflammation; Portal hypertension

Indexed keywords

CREATININE; CYTOKINE; MALONALDEHYDE; NITRATE; NITRITE; NORADRENALIN; BIOLOGICAL MARKER;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; INFLAMMATION; LIVER BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORTALITY; NORADRENALIN BLOOD LEVEL; PRESSURE GRADIENT; AGED; COMPLICATION; HEPATIC ENCEPHALOPATHY; KIDNEY FAILURE; MULTIPLE ORGAN FAILURE; PORTAL HYPERTENSION; PROGNOSIS; PROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; AGED; BIOMARKERS; FEMALE; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84922737775     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12559     Document Type: Article

References (40)

1. Garcia-Pagan JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 2012; 57: 458-61.
2. Iwakiri Y, Grisham M, Shah V. Vascular biology and pathobiology of the liver: report of a single-topic symposium. Hepatology 2008; 47: 1754-63.
3. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology; 144: 1426-37, 1437 e1421-1429.
4. Mortensen C, Andersen O, Krag A, Bendtsen F, Moller S. High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis. Eur J Gastroenterol Hepatol 2012; 24: 619-26.
5. Lemmers A, Gustot T, Durnez A, et al. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol 2009; 156: 518-27.
6. Mookerjee RP, Sen S, Davies NA, et al. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 2003; 52: 1182-7.
7. Stadlbauer V, Wright GA, Banaji M, et al. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology 2008; 134: 111-9.
8. Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004; 10: 1109-19.
9. Jalan R, Stadlbauer V, Sen S, et al. Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care 2012; 16: R227.
10. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
11. American College of Chest Physicians/Society of Critical Care. Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
12. Olson JC, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology 2011; 54: 1864-72.
13. Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006; 26: 348-62.
14. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41: 1169-79.
15. Turnes J, Hernandez-Guerra M, Abraldes JG, et al. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis. Hepatology 2006; 43: 34-41.
16. Lapenna D, Ciofani G, Pierdomenico SD, Giamberardino MA, Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001; 31: 331-5.
17. Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010; 59: 1561-9.
18. Rincon D, Lo Iacono O, Ripoll C, et al. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther 2007; 25: 841-8.
19. Kumar A, Das K, Sharma P, et al. Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci 2009; 54: 869-78.
20. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-33.
21. Ruiz-del-Arbol L, Urman J, Fernandez J, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003; 38: 1210-8.
22. Bellot P, Garcia-Pagan JC, Frances R, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 2010; 52: 2044-52.
23. Steib CJ, Hartmann AC, V Hesler C, et al. Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis. Lab Invest 2010; 90: 1024-32.
24. Arroyo V, Navasa M, Rimola A. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis. Infection 1994; 22(Suppl. 3): S167-75.
25. Zhu Q, Zou L, Jagavelu K, et al. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol 2012; 56: 893-9.
26. Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139: 186-93.
27. Vlachogiannakos J, Saveriadis AS, Viazis N, et al. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Ther 2009; 29: 992-9.
28. Liu H, Lee SS. Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver Int 2008; 28: 640-8.
29. Blendis LM. Circulation in liver disease. Transplant Proc 1993; 25: 1741-3.
30. Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-36.
31. Gaudin C, Braillon A, Poo JL, et al. Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. J Hepatol 1991; 13: 161-8.
32. Albillos A, Lledo JL, Rossi I, et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 1995; 109: 1257-65.
33. Sancho-Bru P, Bataller R, Colmenero J, et al. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2006; 291: G877-84.
34. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997; 40: 664-70.
35. D'Mello C, Swain MG. Liver-brain inflammation axis. Am J Physiol Gastrointest Liver Physiol 2011; 301: G749-61.
36. Flierl MA, Rittirsch D, Nadeau BA, et al. Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE 2009; 4: e4414.
37. Yang S, Koo DJ, Zhou M, Chaudry IH, Wang P. Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1274-81.
38. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-32.
39. Zhou M, Yang S, Koo DJ, et al. The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta 2001; 1537: 49-57.
40. Tage-Jensen U, Henriksen JH, Christensen E, et al. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988; 6: 350-8.